6611 - 6620 of 9145 Results
Title
Year
- Wearable-based mobility monitoring: the long road ahead2020RESTRICTEDTitle: Wearable-based mobility monitoring: the long road aheadJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 378End Page: 379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30033-8Citation Count: 35
- Association of Neurological Family Health History in Parkinson's Diseases2024RESTRICTEDTitle: Association of Neurological Family Health History in Parkinson's DiseasesJournal Name: 2024 International Conference on Brain Computer Interface & Healthcare Technologies (iCon-BCIHT)Publisher: IEEEVol:Issue #:Start Page: 207End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/icon-bciht63907.2024.10882367Citation Count: 1
-
OPENTitle: The 5‐HT2A/2C inverse agonist nelotanserin alleviates L‐DOPA‐induced dyskinesia in the MPTP‐lesioned marmosetJournal Name: European Journal of NeurosciencePublisher: WileyVol: 59Issue #: 6Start Page: 1169End Page: 1176Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/ejn.16104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.16104Citation Count: 4
- Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohort2018RESTRICTEDTitle: Presynaptic striatal dopaminergic depletion predicts the later development of freezing of gait in de novo Parkinson's disease: An analysis of the PPMI cohortJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 51Issue #:Start Page: 49End Page: 54Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.047Citation Count: 89
- Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegeneration2018RESTRICTEDTitle: Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer’s and Parkinson’s disease models of neurodegenerationJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page: 4176End Page: 4193Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddy308Citation Count: 33
- MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat model2013RESTRICTEDTitle: MicroRNA profiling and the role of microRNA-132 in neurodegeneration using a rat modelJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 553Issue #:Start Page: 153End Page: 158Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2013.08.001Citation Count: 66
- TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated Staging2026RESTRICTEDTitle: TDP-43–Associated Neurodegenerative Disease Conceptualization and Integrated StagingJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2026.2812Citation Count: 0
- We Set Out to Break the Mold in Science Philanthropy—It’s Still Not Enough2026RESTRICTEDTitle: We Set Out to Break the Mold in Science Philanthropy—It’s Still Not EnoughJournal Name: JAMAPublisher: American Medical Association (AMA)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2026.15611Citation Count: 0
- Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathies2026OPENTitle: Regulatory endorsement for the application of α-synuclein seed amplification assay as a susceptibility and risk biomarker for clinical trials targeting synucleinopathiesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 6Start Page: 1877718X261463936End Page: 1877718X261463936Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x261463936Citation Count: 0
- Crowdsourcing and machine learning contests in Parkinson's disease research - when do they work?2026OPENTitle: Crowdsourcing and machine learning contests in Parkinson's disease research - when do they work?Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol:Issue #:Start Page: 1877718X261452116End Page: 1877718X261452116Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261452116Best OA location URL: https://doi.org/10.1177/1877718x261452116Citation Count: 0